| Tips : |
Žurnāls |
| Interneta saite : |
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6TGX-3ST2874-3&_user=1592607&_coverDate=10%2F31%2F1997&_rdoc=3&_fmt=summary&_orig=browse&_srch=doc-info(%23toc%235266%231997%23999839997%2311428%23FLT%23display%23Volume)&_cdi=5266&_sort=d&_docanch |
|
| Pētniecības grupas : |
King of Prussia - SmithKline Beecham Pharmaceuticals |
| Autori : |
Craig SB, Bhatt UH, Patel K. |
| Nosaukums : |
Stability and compatibility of topotecan hydrochloride for injection with common infusion solutions and containers. |
| Numurs : |
J Pharm Biomed Anal ; 16: 199-205. 1997 |
|
| Pierādījumu līmeni : |
|
| Fizikālā stabilitāte : |
|
| ķīmiskā stabilitāte : |
|
| Citas metodes : |
|
| Komentāri : |
| Nav veikta vizuāla pārbaude | | Reālos apstākļos degradēšanās produkti nav novēroti |
|
Saraksti
 Topotecan
|
 |
 |
 |
 |
0,05 mg/ml |
23-24°C |
 |
| 24 |
 |
|
|
|
|
|
0,05 mg/ml |
5°C |
 |
| 7 |
 |
|
|
|
 |
|
0,025 mg/ml |
23°C-24°C |
|
| 24 |
|
|
|
|
|
|
0,025 mg/ml |
5°C |
|
| 7 |
|
|
|
|
|
|
0,05 mg/ml |
23-24°C |
|
| 24 |
|
|
|
|
|
|
0,05 mg/ml |
5°C |
|
| 7 |
|
|
|
|
 |
|
0,05 mg/ml |
23-24°C |
|
| 24 |
|
|
|
|
|
|
0,05 mg/ml |
5°C |
|
| 7 |
|
|
|
|
|
